On Thursday 23 May, the European Commission proposed new rules for the joint clinical assessments of medicinal products at EU level, which will help to speed up access to medicines for patients in the EU.
These new rules define the deadlines and stages for carrying out joint clinical assessments in the EU. The assessment reports will provide Member State authorities with scientific evidence at an early stage following the marketing authorisation of a medicinal product. They will help them...